Kimberly Stern is a seasoned professional in the fields of rare disease, cell and gene therapy, and hematology/oncology. Currently serving as Senior Director at Genetix Biotherapeutics, Kimberly is focused on innovative gene therapies for sickle cell disease and beta thalassemia. With a background that includes significant roles in specialty and hospital sales, Kimberly has successfully launched various products and developed comprehensive commercial strategies across multiple biopharmaceutical companies, including CSL Vifor and Keryx Biopharmaceuticals. Kimberly holds a Doctor of Law (JD) from Capital University Law School and is committed to delivering impactful solutions for patients with rare diseases.
This person is not in any teams
This person is not in any offices